Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study

The effect of a pre- and post-operative exercise programme versus standard care on physical fitness of patients with oesophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (The PERIOP-OG Trial): Study protocol for a randomised controlled trial

(2020) Roisin Tully et al.   Trials

Prehabilitative Exercise for the Enhancement of Physical, Psychosocial, and Biological Outcomes Among Patients Diagnosed with Cancer

(2020) Kyuwan Lee et al.   Current Oncology Reports

Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study

(2019) Claire Gallois et al.   EUROPEAN JOURNAL OF CANCER

Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial

(2019) Ulrich T. Hacker et al.   Journal of Cachexia Sarcopenia and Muscle

Impact of remnant stomach volume and anastomosis on nutrition and body composition in gastric cancer patients

(2019) Koeun Lee et al.   SURGICAL ONCOLOGY-OXFORD

Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial

(2018) Hyung Soon Park et al.   ANNALS OF SURGICAL ONCOLOGY

Actual 5-Year Nutritional Outcomes of Patients with Gastric Cancer

(2017) Ki Hyun Kim et al.   Journal of Gastric Cancer

Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer

(2016) Michitaka Honda et al.   ANNALS OF SURGERY

Low Preoperative Prognostic Nutritional Index Predicts Poor Survival Post-gastrectomy in Elderly Patients with Gastric Cancer

(2016) Katsunobu Sakurai et al.   ANNALS OF SURGICAL ONCOLOGY

Japanese gastric cancer treatment guidelines 2014 (ver. 4)

(2016)   Gastric Cancer

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

(2015) Karel G.M. Moons et al.   ANNALS OF INTERNAL MEDICINE

Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes

(2015) Juul J.W. Tegels et al.   JOURNAL OF SURGICAL ONCOLOGY

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

(2014) Sung Hoon Noh et al.   LANCET ONCOLOGY

The Prognostic Nutritional Index Predicts Long-term Outcomes of Gastric Cancer Patients Independent of Tumor Stage

(2013) Kazuhiro Migita et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

(2013) Suee Lee et al.   BMC CANCER

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Definition and classification of cancer cachexia: an international consensus

(2011) Kenneth Fearon et al.   LANCET ONCOLOGY

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Cachexia: prevalence and impact in medicine

(2008) Benjamin HL Tan et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY